Can Statins Alter Coronary Plaque Composition Assessed by Radiofrequency Backscatter Intravascular Ultrasound?

JACC: Cardiovascular Interventions

Volumn 2, Issue 7, 2009, Pages 697-700

  Samady, Habib ^a   McDaniel, Michael C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; imaging; lipids; lipoprotein; plaque

Indexed keywords

ATORVASTATIN; DARAPLADIB; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; EDITORIAL; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVASCULAR ULTRASOUND; PRIORITY JOURNAL; REMISSION;

CALCINOSIS; CORONARY ARTERY DISEASE; FATTY ACIDS, MONOUNSATURATED; FIBROSIS; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; NECROSIS; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PYRIMIDINES; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; USER-COMPUTER INTERFACE;

EID: 67650634985     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.05.006     Document Type: Editorial

References (23)

1. Virmani R., Burke A.P., and Farb A. Plaque rupture and plaque erosion. Thromb Haemost 82 Suppl 1 (1999) 1-3
2. Virmani R., Kolodgie F.D., Burke A.P., Farb A., and Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20 (2000) 1262-1275
3. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 344 (1994) 633-638
4. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
5. Raggi P., Davidson M., Callister T.Q., et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 112 (2005) 563-571
6. Jukema J.W., Bruschke A.V., van Boven A.J., et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91 (1995) 2528-2540
7. Schartl M., Bocksch W., Koschyk D.H., et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 104 (2001) 387-392
8. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 (2004) 1071-1080
9. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
10. Jensen L.O., Thayssen P., Pedersen K.E., Stender S., and Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 110 (2004) 265-270
11. Takarada S., Imanishi T., Kubo T., et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis 202 (2009) 491-497
12. Nair A., Kuban B.D., Tuzcu E.M., Schoenhagen P., Nissen S.E., and Vince D.G. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106 (2002) 2200-2206
13. Nasu K., Tsuchikane E., Katoh O., et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47 (2006) 2405-2412
14. Diethrich E.B., Pauliina Margolis M., Reid D.B., et al. Virtual histology intravascular ultrasound assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study. J Endovasc Ther 14 (2007) 676-686
15. Kawasaki M., Sano K., Okubo M., et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 45 (2005) 1946-1953
16. Nasu K., Tsuchikane E., Katoh O., et al. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. J Am Coll Cardiol Intv 2 (2009) 689-696
17. Hong M.-K., Park D.-W., Lee C.-W., et al. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. J Am Coll Cardiol Intv 2 (2009) 679-688
18. Ogasawara D., Shite J., Shinke T., et al. Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus. Circ J 73 (2009) 343-351
19. Prasad A., Cipher D.J., Prasad A., et al. Reproducibility of intravascular ultrasound virtual histology analysis. Cardiovasc Revasc Med 9 (2008) 71-77
20. Tanaka K., Carlier S.G., Mintz G.S., et al. The accuracy of length measurements using different intravascular ultrasound motorized transducer pullback systems. Int J Cardiovasc Imaging 23 (2007) 733-738
21. Serruys P.W., Garcia-Garcia H.M., Buszman P., et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 118 (2008) 1172-1182
22. Hirayama A., Saito S., Ueda Y., et al. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. Circ J 73 (2009) 718-725
23. Miyagi M., Ishii H., Murakami R., et al. Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: a nonrandomized study of the history of long-term statin treatment before coronary angioplasty. Clin Ther 31 (2009) 64-73